SCHEMBL3056740

SCHEMBL3056740

COc1ccc(C(=O)N2CCc3cc(OCc4ccccc4)c(OC)cc3C2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.68
MEN1 O00255 2/20 0.68
PDE4B Q07343 3/20 0.63
PDE4D Q08499 2/20 0.63
MAPT P10636 2/20 0.61
LMNA P02545 1/20 0.61
CHRNA7 P36544 2/20 0.61
MAPK1 P28482 1/20 0.60
GPR183 P32249 1/20 0.60
NPC1 O15118 1/20 0.60
KDM4E B2RXH2 1/20 0.57
ALOX15 P16050 1/20 0.57
HSD17B10 Q99714 1/20 0.57
CA1 P00915 1/20 0.57
CA2 P00918 1/20 0.57
CA7 P43166 1/20 0.57
CA9 Q16790 1/20 0.57
CA14 Q9ULX7 1/20 0.57
ABCB1 P08183 2/20 0.57
ALDH1A1 P00352 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3056795 0.92 KMT2A (0.62) KMT2AMEN1PDE4BMAPTLMNA
SCHEMBL9416605 0.91 LMNA (0.75) KMT2AMEN1PDE4BPDE4DMAPT
SCHEMBL3055130 0.90 PDE4B (0.66) KMT2AMEN1PDE4BMAPTLMNA
SCHEMBL3046120 0.88 KMT2A (0.63) KMT2AMEN1PDE4BPDE4DMAPT
SCHEMBL3041866 0.88 KMT2A (0.62) KMT2AMEN1PDE4BMAPTLMNA
SCHEMBL3056571 0.85 KDM4E (0.69) KMT2AMEN1PDE4BMAPTLMNA
SCHEMBL9667825 0.85 CHRNA7 (0.69) KMT2AMEN1MAPTCHRNA7GPR183
SCHEMBL9668362 0.85 CHRNA7 (0.69) KMT2AMEN1MAPTCHRNA7GPR183
SCHEMBL3052486 0.84 MAPK1 (0.64) KMT2AMEN1PDE4BPDE4DMAPT
SCHEMBL7893969 0.83 KMT2A (0.85) KMT2AMEN1PDE4BPDE4DMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100222299-A1 COMPOUND STERIX LIMITED (GB) 2010-09-02 US claimed
US-8394825-B2 Compound STERIX LIMITED (GB) 2013-03-12 US disclosed
US-20100222299-A1 COMPOUND STERIX LIMITED (GB) 2010-09-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100222299-A1 COMPOUND MKI67, VHL, MYC KMT2A 924/4885MEN1 305/4885PDE4B 1822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.